We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A postmarket study of a biometric chest patch and remote monitoring platform from Israel’s Biobeat Technologies showed a greater ability to identify patients with a high risk of health deterioration as compared to the standard National Early Warning Score (NEWS).
Two recent studies found that the DermaSensor skin cancer detection device showed a 94 percent sensitivity for correctly classifying high-risk skin cancer lesions, exceeding the accuracy of primary care physicians (PCPs).
Pain and bleeding were reduced in a clinical trial testing Aspivix’s Carevix cervical stabilizer device against a standard tenaculum — used to stabilize the cervix to ease passage of instruments — among women undergoing intrauterine device (IUD) placement to prevent pregnancy.
Abbott’s MitraClip cut the rate of hospitalizations while improving survival for heart failure patients with severe secondary mitral valve regurgitation (MR) in a five-year study at multiple U.S. medical centers.
To help prevent the approval of AI medical devices that “mirror or exacerbate” existing health disparities, the FDA should develop a “distinct regulatory process” for artificial intelligence (AI)-driven software as a medical device (SaMD), say several academic researchers.
BlueStar Telehealth reported that its in-home remote patient monitoring program (RPM) using SmartMeter’s iBloodPressure cellular-connected blood pressure devices saw improvements in all patients with uncontrolled hypertension.